Determining the adjuvant effects of ginger capsules on the reduction of generalized anxiety disorder in concomitant use of SSRIs compared with placebo, which means in comparison with the reduction of generalized anxiety disorder in patients taking SSRIs and starch capsules
Design
This study is a phase 2 3 clinical trial with eighty participants.
Forty patients in intervention group: SSRI drug with specific dose + two capsules of 500 mg of ginger per day
Forty patients in control group: SSRI drug with specific dose + two starch capsules per day
For randomization, we will use the method of foursome Block Randomization. (Two intervention sheets and two control sheets and random selection between these four sheets for each patient until the completion of four sheets then repeating this procedure)
Settings and conduct
This study is a randomized clinical trial which will be performed on patients with generalized anxiety disorder referred to the psychiatric clinic of Sina Hospital or a psychiatrist's private office within 12 weeks (while taking given SSRI drug with ginger or starch). The patients will be blinded whether they are taking ginger or placebo beside the SSRI drug
Participants/Inclusion and exclusion criteria
Diagnosis of generalized anxiety disorder by the physician and the patient's informed consent to participate in the study, the participants being in the age group of 18 to 65 years old and not having an accompanying disease, and also the participants should not be pregnant or breastfeeding
Intervention groups
Eighty patients with generalized anxiety disorder with study criteria are randomly divided into two intervention or control groups, the first group is given SSRI drug and ginger rhizome powder capsules and the group Second, we give SSRIs and placebo capsules
Main outcome variables
The severity and extent of recovery from anxiety according to Hamilton Anxiety Rating Scale
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20201108049306N1
Registration date:2021-01-29, 1399/11/10
Registration timing:prospective
Last update:2021-01-29, 1399/11/10
Update count:0
Registration date
2021-01-29, 1399/11/10
Registrant information
Name
Sina Anaraki
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3775 0343
Email address
sinaanaraky@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-03-05, 1399/12/15
Expected recruitment end date
2021-09-06, 1400/06/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of ginger as an adjunct therapy along with SSRIs to reduce anxiety inpatients with Generalized Anxiety Disorder (GAD)
Public title
Evaluation of ginger as an adjunct therapy in Generalized Anxiety Disorder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Diagnosis of Generalized Anxiety Disorder by a physician based on the Hamilton Anxiety Rating Scale
The patient has filled in the consent form and consciously enters the study and cooperates
Age group 18 to 65 years old
Exclusion criteria:
The patient is pregnant or breastfeeding
The patient has a major co-morbid psychological disorder (including depressive disorder, bipolar disorder, psychosis, and drug use)
The patient has taken any antioxidant medication or supplement in the past month
Taking medicine that has interaction with ginger
The patient has co-morbid disease (other than neurological diseases)
Age
From 18 years old to 65 years old
Gender
Both
Phase
2-3
Groups that have been masked
Participant
Investigator
Data analyser
Sample size
Target sample size:
80
Randomization (investigator's opinion)
Randomized
Randomization description
The method of block randomization with individual units by preparing four sheets of paper. On the two sheets we write the letter "I" meaning "Intervention" and on the other two sheets we write the letter "P" meaning "Placebo". Mix the sheets together and place them in the desk drawer. With the referral of each eligible patient, one of the sheets is randomly pulled out and based on this sheet whether it is "I" or "P", they will be assigned to one of the two intervention or control groups.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients are blinded that they are taking ginger or starch capsules and all of them are told they are taking ginger capsules along with the prescribed SSRI. The researcher is also blind to whether patients are receiving ginger or not (Only the doctor or clinical caregiver is not blinded). The method of blinding is that the doctor who has four sheets in his desk drawer (two "i" sheets that means "Intervention" and two "p" sheets that means "Placebo") by referring to each of the eligible patients, one of the sheets Randomly taken out and based on this sheet, I or P, will be assigned to one of the two intervention or control groups, and the doctor will record that each patient belongs to intervention group or placebo group. It should be noted that the pulled out sheets will not be returned to the drawer until all four sheets have been pulled out. After accidentally pulling out all four sheets, all the sheets are returned to the drawer and the above procedure will be continued for the next four patients until the desired sample size is reached.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Hamedan University of Medical Sciences
Street address
Research Ethics Committees, Vice Chancellor for Research and Technology, Hamedan University of Medical Sciences
City
Hamedan
Province
Hamadan
Postal code
6517838678
Approval date
2020-11-07, 1399/08/17
Ethics committee reference number
IR.UMSHA.REC.1399.680
Health conditions studied
1
Description of health condition studied
Generalized Anxiety Disorder (GAD)
ICD-10 code
F41.1
ICD-10 code description
Generalized anxiety disorder
Primary outcomes
1
Description
Score of anxiety based on the Hamilton Anxiety Rating Scale
Timepoint
Measurement of severity and extent of improvement of anxiety at the beginning of the study (before the intervention) and 14, 28, 56 and 84 days after the start of use
Method of measurement
Hamilton Anxiety Rating Scale
Secondary outcomes
empty
Intervention groups
1
Description
Forty people in intervention group: Patients under treatment with SSRI at a specific dose (Sertraline oral tablets at the dose of 25 mg once daily and may be increased to 100 mg daily, or Citalopram 10 mg oral tablets once daily and may be increased to 40 mg daily) for 12 weeks + two 500 mg ginger capsules per day for 12 weeks Patients' visits may last from 20 minutes to an hour long of doctor's visit and questions and answers (filling out questionnaires) by the researcher. These visits will occur at the time of diagnosis, two weeks later, and also 4, 8, and 12 weeks after the first visit and diagnosis of GAD.
Category
Treatment - Drugs
2
Description
Control group: Patients under treatment with SSRI at a specific dose (Sertraline oral tablets at the dose of 25 mg once daily and may be increased to 100 mg daily, or Citalopram oral tablets 10 mg once daily and may be increased to 40 mg daily) for 12 weeks + two starch capsules per day (placebo) for 12 weeks Patients' visits may last from 20 minutes to an hour long of doctor's visit and questions and answers (filling out questionnaires) by the researcher. These visits will occur at the time of diagnosis, two weeks later, and also 4, 8, and 12 weeks after the first visit and diagnosis of GAD.
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Farshchian (Sina) Hospital
Full name of responsible person
Lila Jahangard
Street address
Mirzadeh Eshqi St.
City
Hamedan
Province
Hamadan
Postal code
6516848741
Phone
+98 81 3827 9345
Email
farsh_hamedan@umsha.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Shirin Sharifi
Street address
Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences, in front of Mardom Park, Shahid Fahmideh St.
City
Hamedan
Province
Hamadan
Postal code
6517838678
Phone
+98 81 3838 0267
Email
Shirin.sharifi@umsha.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Hamedan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Sara Ataei
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Medical Pharmacy
Street address
School of Pharmacy, Hamadan University of Medical Science, Shahid Fahmideh Blvd., Hamadan
City
Hamedan
Province
Hamadan
Postal code
6517838678
Phone
+98 81 3838 1591
Email
s.ataei@umsha.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Sara Ataei
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Medical Pharmacy
Street address
School of Pharmacy, Hamadan University of Medical Science, Shahid Fahmideh Blvd., Hamadan
City
Hamedan
Province
Hamadan
Postal code
6517838678
Phone
+98 81 3838 1591
Email
s.ataei@umsha.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Sina Anaraki
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
Medical Pharmacy
Street address
No. 90, Nader Beigi Ave., Javadieh St., Hamedan
City
Hamedan
Province
Hamadan
Postal code
6541956191
Phone
+98 31 3132 9138
Email
sinaanaraky@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available